Developer docs
API playgroundTry for free, no card

Search company profiles

Zenabis Global

Full company profile

uuid0006d1v

Namestring
Zenabis Global
Legal namestring
SNDL Inc.
Websiteurl
zenabis.com
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Zenabis Global was a Canadian licensed producer of medical and recreational cannabis, founded in 2013 and headquartered in Vancouver, British Columbia, with operations spanning coast-to-coast and a workforce of 501–1,000 employees. The company's core business revolved around federally licensed cannabis cultivation and production, supported by proprietary cannabis product brands distributed through Canadian retail channels. In January 2019, Zenabis extended its product portfolio beyond core cannabis categories via the acquisition of True Buch Kombucha, entering the cannabis-infused beverage adjacency. The executive team was structured for multi-disciplinary scale, including dedicated officers for growing operations, science, medicine, finance, administration, and revenue — a configuration typical of vertically integrated licensed producers building out production, clinical, and commercial functions in parallel.

The company's go-to-market operated through wholesale distribution into provincial cannabis retailers and direct-to-consumer medical channels (where permitted), with a brand portfolio strategy designed to differentiate SKUs at the point of retail sale. Zenabis financed its scaling through approximately $94 million raised across five separate capital markets rounds between March 2019 and September 2020, a cadence consistent with aggressive cultivation-capacity expansion during the Canadian recreational market build-out. Disclosed annual revenue progressed from approximately $5.1M in 2018 to $23.4M in 2019 to $46.6M in 2020, reflecting hyper-growth in the post-legalization period.

Zenabis Global's CVE:ZENA stock is recorded as delisted, and significant firmographic data attached to this entity in the input (legal name SNDL Inc., SNDL/Sundial Growers DBAs, Alberta domicile, Q1 2026 financial reporting cadence, retail-banner product descriptions spanning liquor and cannabis) appears to pertain to the surviving acquirer SNDL Inc. rather than Zenabis Global on a standalone basis. This data conflation materially limits any standalone analysis of Zenabis Global's post-2020 scale, customer mix, or commercial footprint; readers should treat post-2020 retail-banner and liquor-distribution signals as SNDL Inc. attributes rather than evidence of Zenabis Global's continuing operations.

Short descriptiontext

Zenabis Global was a Canadian federally licensed producer of medical and recreational cannabis, founded in 2013 in Vancouver, operating cultivation, production, and proprietary-brand distribution coast-to-coast across Canada with 501–1,000 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis production, medical cannabis, recreational cannabis, licensed producer, cannabis cultivation
Industry2 codes
PRIMARYCRANAFAA
Adult-Use (Recreational) Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Licensed Cannabis Production
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Zenabis Global is a licensed Canadian producer of medical and recreational cannabis, employing 501-1,000 staff across coast-to-coast operations. The company cultivates, processes, and distributes cannabis products through wholesale and B2B channels, and operates the True Buch Kombucha product line acquired in 2019.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SNDL Inc. operates as a vertically integrated cannabis and liquor company with two primary business segments: retail operations (liquor and cannabis retail banners) and B2B services including lab services. The company owns multiple retail banners and cannabis brands, distributing products through physical store locations.

Product and service3 records
1Medical Cannabis
CategoryMedical Cannabis
Description

Health Canada-licensed medical cannabis products supplied to registered patients and wholesale buyers for therapeutic use.

2Recreational Cannabis
CategoryRecreational Cannabis
Description

Health Canada-licensed recreational cannabis products produced for the Canadian adult-use cannabis market.

3True Buch Kombucha
CategoryFermented Beverages
Description

Kombucha beverage product line added to Zenabis's portfolio through the 2019 acquisition of True Buch Kombucha.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Canadian cannabis derivatives and white-label manufacturer — comparable on the B2B services, lab/derivatives and white-label production angle of Zenabis' business.

TypeDirect peer
Description

One of the largest Canadian licensed producers of medical and recreational cannabis, operating branded products, retail and B2B channels — directly comparable to Zenabis across cultivation, branded flower and downstream Canadian retail.

3Tilray Brands
TypeDirect peer
Description

Canadian-headquartered licensed producer with branded cannabis, ancillary beverage/CPG exposure and international distribution — comparable in scale of cultivation footprint, branded portfolio strategy and adjacency diversification (e.g. beverages).

TypeDirect peer
Description

Major Canadian licensed producer focused on medical and recreational cannabis with national production footprint — directly comparable on cultivation scale, regulatory exposure and Canadian wholesale/banner relationships.

TypeDirect peer
Description

Canadian licensed producer with branded recreational and medical products sold nationally — comparable as a mid-to-large LP competing for the same provincial wholesale contracts and retail-banner shelf space.

TypeDirect peer
Description

Canadian licensed producer with branded cannabis and international operations — comparable as a federally regulated LP operating in the same wholesale and branded-retail ecosystem.

TypeBroad incumbent
Description

Public Canadian cannabis and liquor retailer with owned retail banners, branded cannabis and B2B services — overlaps directly with Zenabis' downstream branded, retail and B2B/services segments and is the acquirer in Zenabis' delisting context.

TypeDirect peer
Description

Canadian cannabis retail-focused operator with national banner footprint and ancillary CPG — directly comparable on retail-banner strategy and consumer-facing cannabis distribution in Canada.

TypeRegional player
Description

US-focused cannabis cultivator and retailer with branded portfolio and retail-banner strategy — comparable in operating model (LP + branded + retail) but operates in the US market, not directly competing with Zenabis in Canada.

TypeRegional player
Description

Vertically integrated cannabis operator combining cultivation, branded products and flagship retail experiences — comparable on the integrated production-to-retail thesis, but US-based and therefore not a direct Canadian competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zenabis Global

Licensed Cannabis Productionzenabis.com

Zenabis Global was a Canadian federally licensed producer of medical and recreational cannabis, founded in 2013 in Vancouver, operating cultivation, production, and proprietary-brand distribution coast-to-coast across Canada with 501–1,000 employees.

What Zenabis Global does

Zenabis Global was a Canadian licensed producer of medical and recreational cannabis, founded in 2013 and headquartered in Vancouver, British Columbia, with operations spanning coast-to-coast and a workforce of 501–1,000 employees. The company's core business revolved around federally licensed cannabis cultivation and production, supported by proprietary cannabis product brands distributed through Canadian retail channels. In January 2019, Zenabis extended its product portfolio beyond core cannabis categories via the acquisition of True Buch Kombucha, entering the cannabis-infused beverage adjacency. The executive team was structured for multi-disciplinary scale, including dedicated officers for growing operations, science, medicine, finance, administration, and revenue — a configuration typical of vertically integrated licensed producers building out production, clinical, and commercial functions in parallel.

The company's go-to-market operated through wholesale distribution into provincial cannabis retailers and direct-to-consumer medical channels (where permitted), with a brand portfolio strategy designed to differentiate SKUs at the point of retail sale. Zenabis financed its scaling through approximately $94 million raised across five separate capital markets rounds between March 2019 and September 2020, a cadence consistent with aggressive cultivation-capacity expansion during the Canadian recreational market build-out. Disclosed annual revenue progressed from approximately $5.1M in 2018 to $23.4M in 2019 to $46.6M in 2020, reflecting hyper-growth in the post-legalization period.

Zenabis Global's CVE:ZENA stock is recorded as delisted, and significant firmographic data attached to this entity in the input (legal name SNDL Inc., SNDL/Sundial Growers DBAs, Alberta domicile, Q1 2026 financial reporting cadence, retail-banner product descriptions spanning liquor and cannabis) appears to pertain to the surviving acquirer SNDL Inc. rather than Zenabis Global on a standalone basis. This data conflation materially limits any standalone analysis of Zenabis Global's post-2020 scale, customer mix, or commercial footprint; readers should treat post-2020 retail-banner and liquor-distribution signals as SNDL Inc. attributes rather than evidence of Zenabis Global's continuing operations.

Zenabis Global firmographics

Firmographics
Name
Zenabis Global
Legal name
SNDL Inc.
Website
https://zenabis.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
Zenabis Global was a Canadian federally licensed producer of medical and recreational cannabis, founded in 2013 in Vancouver, operating cultivation, production, and proprietary-brand distribution coast-to-coast across Canada with 501–1,000 employees.
Ownership category
akta.pro rank

Zenabis Global industry classification

Industry
Product category
Licensed Cannabis Production
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRANAFAA
Adult-Use (Recreational) Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Cannabis production
  • Medical cannabis
  • Recreational cannabis
  • Licensed producer
  • Cannabis cultivation

Where Zenabis Global is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Markets served

Zenabis Global business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Distribution channels4 records

Marketing channels3 records

Zenabis Global product offering

Product offering

Core offering

Zenabis Global is a licensed Canadian producer of medical and recreational cannabis, employing 501-1,000 staff across coast-to-coast operations. The company cultivates, processes, and distributes cannabis products through wholesale and B2B channels, and operates the True Buch Kombucha product line acquired in 2019.

Product overview

SNDL Inc. operates as a vertically integrated cannabis and liquor company with two primary business segments: retail operations (liquor and cannabis retail banners) and B2B services including lab services. The company owns multiple retail banners and cannabis brands, distributing products through physical store locations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Health Canada-licensed medical cannabis products supplied to registered patients and wholesale buyers for therapeutic use.
  • Recreational Cannabis Health Canada-licensed recreational cannabis products produced for the Canadian adult-use cannabis market.
  • True Buch Kombucha Kombucha beverage product line added to Zenabis's portfolio through the 2019 acquisition of True Buch Kombucha.

Companies that use Zenabis Global

Customer profile

Segments3 records

Ideal customer profiles2 records

Zenabis Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Zenabis Global partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Zenabis Global competitors and assessment

Company assessment

Emerging players

  • The Valens Company: Canadian cannabis derivatives and white-label manufacturer — comparable on the B2B services, lab/derivatives and white-label production angle of Zenabis' business.

Direct peers

  • Canopy Growth Corporation: One of the largest Canadian licensed producers of medical and recreational cannabis, operating branded products, retail and B2B channels — directly comparable to Zenabis across cultivation, branded flower and downstream Canadian retail.
  • Tilray Brands: Canadian-headquartered licensed producer with branded cannabis, ancillary beverage/CPG exposure and international distribution — comparable in scale of cultivation footprint, branded portfolio strategy and adjacency diversification (e.g. beverages).
  • Aurora Cannabis: Major Canadian licensed producer focused on medical and recreational cannabis with national production footprint — directly comparable on cultivation scale, regulatory exposure and Canadian wholesale/banner relationships.
  • OrganiGram Holdings: Canadian licensed producer with branded recreational and medical products sold nationally — comparable as a mid-to-large LP competing for the same provincial wholesale contracts and retail-banner shelf space.
  • Cronos Group: Canadian licensed producer with branded cannabis and international operations — comparable as a federally regulated LP operating in the same wholesale and branded-retail ecosystem.
  • High Tide Inc. Canadian cannabis retail-focused operator with national banner footprint and ancillary CPG — directly comparable on retail-banner strategy and consumer-facing cannabis distribution in Canada.

Broad incumbents

  • SNDL Inc. Public Canadian cannabis and liquor retailer with owned retail banners, branded cannabis and B2B services — overlaps directly with Zenabis' downstream branded, retail and B2B/services segments and is the acquirer in Zenabis' delisting context.

Regional players

  • Green Thumb Industries: US-focused cannabis cultivator and retailer with branded portfolio and retail-banner strategy — comparable in operating model (LP + branded + retail) but operates in the US market, not directly competing with Zenabis in Canada.
  • Planet 13 Holdings: Vertically integrated cannabis operator combining cultivation, branded products and flagship retail experiences — comparable on the integrated production-to-retail thesis, but US-based and therefore not a direct Canadian competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Zenabis Global social profiles

Digital presence

Zenabis Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zenabis Global leadership team

Management profile

Number of profiles

Profiles8 records

Zenabis Global funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zenabis Global M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenabis Global

What does Zenabis Global do?

Zenabis Global is a licensed Canadian producer of medical and recreational cannabis, employing 501-1,000 staff across coast-to-coast operations. The company cultivates, processes, and distributes cannabis products through wholesale and B2B channels, and operates the True Buch Kombucha product line acquired in 2019.

Is Zenabis Global a public or private company?

Zenabis Global is a public company. It is classified as corporate owned and is currently operating.

When was Zenabis Global founded?

Zenabis Global was founded in 2013. It employs 51 to 100 people.

Where is Zenabis Global based?

Zenabis Global is headquartered in Vancouver, Canada, in the North America region.

Who are Zenabis Global's main competitors?

The Valens Company is listed as an emerging player. Direct peers are Canopy Growth Corporation, Tilray Brands, Aurora Cannabis, OrganiGram Holdings, Cronos Group and High Tide Inc.. SNDL Inc. is listed as a broad incumbent. Regional players are Green Thumb Industries and Planet 13 Holdings.

Does Zenabis Global have an API?

No public API is recorded for Zenabis Global.

What industry is Zenabis Global in?

Zenabis Global's product category is Licensed Cannabis Production. Its primary akta.pro industry code is CRANAFAA, Adult-Use (Recreational) Cannabis Dispensaries, with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketWatchSNDL buys cultivation facility as part of Zenabis dealSNDL Inc. plans to add a 380,000-square-foot indoor growing facility in Atholville, New Brunswick, to its cannabis exporting business as part of its Zenabis acquisition. The facility has an annual production capacity of about 46,000 kilograms of dried cannabis and 15,000 kilograms of extraction capacity. SNDL shares rose 2% in premarket trades.PR NewswireSNDL Acquires Zenabis BusinessSNDL Inc. announced the successful closing of its acquisition of the Zenabis Business through proceedings under the Companies' Creditors Arrangement Act, approved by the Québec Superior Court. The transaction gives SNDL a 380,000-square-foot indoor cultivation facility in Atholville, New Brunswick with annual production capacity of approximately 46,000 kg of dried cannabis and 15,000 kg extraction capacity, along with over 22 million grams of cannabis inventory and a 255,000-square-foot industrial facility in Stellarton, Nova Scotia. SNDL, which operates 185 retail stores across Canada, expects to monetize the acquired inventory through wholesale transactions, international export, and branded product sales while expanding its international export capabilities using Zenabis' existing customer relationships and EU GMP-certified facility.GlobeNewswireHEXO Announces Filing of Early Warning Report in Respect of the Former Zenabis Global Inc.HEXO filed an early warning report regarding Zenabis Global Inc. after the Superior Court of Québec issued an approval and vesting order. The company no longer holds any shares or interests in Zenabis or its subsidiaries, having exchanged them for shares of a newly formed corporation that were then cancelled for no consideration.Toronto StarSundial Growers signs deal to make stalking horse bid for Zenabis GroupSundial Growers agreed to make a stalking horse bid to acquire Zenabis Group, which obtained court protection from creditors last week. The bid sets a minimum acceptable price for Zenabis's business and assets, including an indoor growing facility in Atholville, N.B., with 46,000 kg annual production capacity.BenzingaSundial Growers Enters Into Bid Agreement For Zenabis Global Inc.'s Assets, Here's What We Know - SNDL (NSundial Growers Inc. has entered into a stalking horse bid agreement to acquire Zenabis Global Inc. and its subsidiaries through a Companies' Creditors Arrangement Act (CCAA) process in Canada, subject to Québec Superior Court approval. The acquisition includes a 380,000 square foot EU GMP-certified indoor growing facility in Atholville, New Brunswick with 46,000 kgs annual dried cannabis production capacity, plus a decommissioned 255,000 sq. ft. facility in Stellarton, Nova Scotia, with approximately $108 million in total capital invested across both facilities. The deal is designed to create continuity for Zenabis Group's operations and over 100 employees, with Sundial CEO Zach George stating the company is committed to assisting Zenabis in good faith with its restructuring.PR NewswireSundial Growers Enters into a Bid Agreement for Zenabis Global Inc.'s AssetsSundial Growers entered a stalking horse bid agreement to acquire Zenabis Global's assets, including a 380,000 sq ft indoor facility in New Brunswick with EU GMP certification. The facility has an annual production capacity of 46,000 kgs of dried cannabis and 15,000 kgs of extraction capacity. The bid sets a minimum acceptable offer pending court approval and bidding procedures.MjbizdailyCanadian cannabis company Zenabis Global files for creditor protectionZenabis Global, a subsidiary of Hexo Corp., filed for creditor protection under Canada's CCAA to restructure. The company cited margin pressures, operational underperformance, and debt, and expects a stay of creditor claims. Ernst & Young was appointed monitor.GlobeNewswireHEXO Corp. and Zenabis Global Inc. Announce Closing of ArrangementHEXO Corp. completed its acquisition of Zenabis Global Inc. via a plan of arrangement, with each Zenabis share converted to 0.01772 HEXO shares. Zenabis shares will be de-listed from the TSX on or about June 2, 2021, and listed Zenabis warrants will trade under 'HEXO.WT' from June 3, 2021.GlobeNewswireHEXO Corp. and Zenabis Global Inc. Announce Closing of ArrangementHEXO Corp. completed its acquisition of Zenabis Global Inc. via a plan of arrangement, with each Zenabis share converted to 0.01772 HEXO shares. Zenabis shares will be de-listed from the TSX on or about June 2, 2021, and listed Zenabis warrants will trade under 'HEXO.WT' from June 3.YahooHEXO to acquire Zenabis in $235M all-stock dealHEXO announced a $235 million all-stock deal to acquire Zenabis, aiming to become a top three licensed producer in Canada's recreational cannabis market. The deal includes a 19% premium and $20 million in annual savings, with Zenabis shareholders receiving 0.01772 HEXO shares per Zenabis share. The transaction requires regulatory approval and over 66% Zenabis shareholder support.